MedTrace Logo

MRS and Medication Response: A Pilot Study

NCT03254342 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 3

Last updated 2021-08-19

No results posted yet for this study

Summary

We hope to demonstrate that magnetic resonance spectroscopy can detect brain concentration levels of paroxetine (Paxil) or citalopram (Celexa) or escitalopram (Lexapro) in depressed patients.

Conditions

  • Major Depressive Disorder
  • Major Depressive Episode
  • Major Depressive Disorder, Recurrent
  • Major Depression Mild
  • Major Depression Moderate
  • Major Depression Severe

Sponsors & Collaborators

Eligibility

Min Age
21 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-08-06
Primary Completion
2020-08-06
Completion
2020-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03254342 on ClinicalTrials.gov